Aterian Reports Fourth Quarter & Full Year 2022 Results
09 mars 2023 16h15 HE
|
Aterian, Inc
Achieved Substantial Progress Selling Through High Cost Inventory to Drive Margin Expansion Starting In the First Quarter of 2023 Reaffirms Second Half 2023 Adjusted EBITDA Profitability Target ...
Aterian Reports First Quarter 2022 Results
09 mai 2022 16h15 HE
|
Aterian, Inc
Reports First Quarter 2022 Net Revenue of $41.7 Million First Quarter Cash Balance of $44.3 Million NEW YORK, May 09, 2022 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the...
ARKO Corp. Set to Join Russell 2000 Index
16 juin 2021 07h00 HE
|
ARKO Corp.
RICHMOND, Va., June 16, 2021 (GLOBE NEWSWIRE) -- ARKO Corp. (Nasdaq: ARKO) (“ARKO” or the “Company”), a growing leader in the U.S. convenience store industry, is set to join the broad-market Russell...
Aterian Announces Addition To The Russell 2000 Index
14 juin 2021 10h38 HE
|
Aterian, Inc.
NEW YORK, June 14, 2021 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”) announced today that it is set to join the small-cap Russell 2000 Index and broad-market Russell...
Kinnate Biopharma Inc. Announces Its Addition to the Russell 2000® Index
19 mars 2021 16h05 HE
|
Kinnate Biopharma
SAN FRANCISCO and SAN DIEGO, March 19, 2021 (GLOBE NEWSWIRE) -- Kinnate Biopharma Inc. (Nasdaq: KNTE) (“Kinnate”), a biopharmaceutical company focused on the discovery and development of small...